Indication

Hypouricemia

1 clinical trial

1 product

Clinical trial

A Dose Escalation Study of IG3018 to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

Status: Not yet recruiting, Estimated PCD: 2025-06-01

Product